Scotland · NHS Scotland MSAN
Disopyramide (Rythmodan®) 100mg capsules and disopyramide (Rythmodan
MSAN(2026)20 · Level 2 · issued 25 Jun 2026
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Disopyramide (Rythmodan®) 100mg capsules will be in out of stock from late June 2026 | Out of stock | — |
| stock from late June until late July 2026 and can support a partial uplift in demand once | Available — partial uplift only | late July 2026 |
| in limited supply and cannot support an uplift in demand. | Limited supply | — |
| treatment for patients who do not have sufficient supply until stock is available in late July | Available | stock is available in late July |
| with the SPS website. Registration for access to the website is available to UK healthcare | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2026:20
- Recorded
- 06 Aug 2026 21:25 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 06 Aug 2026 21:25 UTC
- Content hash
442e5421362bd976ef8e3ba8b96a15beb4e469273a2b60a0b5898cf1b76fc7efsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2026-20.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.